Literature DB >> 7531714

Identification of transformed alpha 2-macroglobulin as a growth hormone-binding protein in human blood.

J Kratzsch1, T Selisko, G Birkenmeier.   

Abstract

We have found that the human GH forms complexes with the purified proteinase inhibitor, alpha 2-macroglobulin. This inhibitor occurs in two different forms in human blood, known as native and transformed alpha 2-macroglobulin. It could be clearly demonstrated by chromatography and electrophoresis combined with autoradiography that the GH binds specifically to the transformed inhibitor, but not to the native protein. The binding was characterized as being mainly noncovalent to specific binding sites present only in the transformed inhibitor molecule. Binding analysis using antibody precipitation technique revealed two different classes of binding sites with dissociation constants of 0.49 +/- 0.12 and 61 +/- 8 mumol/L for high and low affinity binding sites, respectively. Distribution analysis of 125I-labeled GH in whole plasma suggested that the hormone is bound to different proteins: 1) to the high affinity GH-binding protein, and 2) to the low affinity GH-binding protein identified as transformed alpha 2-macroglobulin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531714     DOI: 10.1210/jcem.80.2.7531714

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Plasma concentration of total and transformed alpha 2-macroglobulin in systemic sclerosis.

Authors:  G Birkenmeier; R Frank
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

Review 2.  Alpha-2-macroglobulin as a radioprotective agent: a review.

Authors:  Xueying Chen; Xiangbo Kong; Zhaoqiang Zhang; Wei Chen; Jieyu Chen; Huanyang Li; Wanting Cao; Yaping Ge; Silian Fang
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

3.  Noncanonical suppression of GH-dependent isoforms of cytochrome P450 by the somatostatin analog octreotide.

Authors:  Rajat Kumar Das; Sarmistha Banerjee; Bernard H Shapiro
Journal:  J Endocrinol       Date:  2013-01-02       Impact factor: 4.286

4.  Prognostic potential of a PSA complex in sera of prostate cancer patients with alpha2-macroglobulin deficiency.

Authors:  Yuhsaku Kanoh; Tadashi Ohara; Shin Egawa; Shiro Baba; Tohru Akahoshi
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

5.  Hepcidin bound to α2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels.

Authors:  Michael Li-Hsuan Huang; Christopher J D Austin; Marie-Agnès Sari; Yohan Suryo Rahmanto; Prem Ponka; Daniel Vyoral; Des R Richardson
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

Review 6.  Growth hormone variants: a potential avenue for a better diagnostic characterization of growth hormone deficiency in children.

Authors:  A E Rigamonti; M Bozzola; G Banfi; C Meazza; E E Müller; S G Cella
Journal:  J Endocrinol Invest       Date:  2012-10-01       Impact factor: 5.467

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.